secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2023-10-25T23:59:59+00:00
Accession:  0001174947-23-001234
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED Q3 sales $304.6M (+10.7% YoY); adj. EPS $0.90 (+16.9%); raises FY guidance
--------------------------------------------------------------------------------

- Revenue of $304.6M, +10.7% reported (+11.9% constant currency). Domestic +9.5%, International +12.3%.
- GAAP diluted EPS $0.50 (vs $1.48); Adjusted diluted EPS $0.90, up 16.9% from $0.77.
- General Surgery sales $179.9M (+15% reported); Orthopedic Surgery $124.7M (+5.1%).
- Full-year revenue guidance raised to $1.24B-$1.26B; adj. EPS guidance raised to $3.45-$3.55.
- Adjusted EBITDA margin 19.6% vs 19.4% prior year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000117494723001234/0001174947-23-001234-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000117494723001234/form8k-30967_cnmd.htm
  HTML page:      https://secwatch.observer/filing/0001174947-23-001234

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer